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Résumé 
La performance diagnostic des signes et symptômes de la grippe a principalement été étudiée 
dans le cadre d'études contrôlées avec des critères d'inclusion stricts. 
Il apparaît nécessaire d'évaluer ces prédicteurs dans le cadre d'une consultation ambulatoire 
habituelle en tenant compte du délai écoulé entre le début des symptômes et la première 
consultation ainsi que la situation épidémiologique. 
Cette étude prospective a été menée à la Policlinique Médicale Universitaire durant l'hiver 
1999-2000. Les patients étaient inclus s'ils présentaient un syndrome grippal et si le praticien 
suspectait une infection à Influenza. Le médecin administrait un questionnaire pms une 
culture d'un frottis de gorge était réalisée afin de documenter l'infection. 
201 patients ont été inclus dans l'étude. 52% avaient une culture positive pour Influenza. En 
analyse univariée, une température > 37.8° (OR 4.2 ;95% CI 2.3-7.7), une durée des 
symptômes< 48h (OR 3.2; 1.8-5.7), une toux (OR 3.2; 1-10.4) et des myalgies (OR 2.8; 1.0-
7.5) étaient associés au diagnostic de grippe. En analyse de régression logistique, le modèle 
le plus performant qui prédisait la grippe était l'association d'une durée des symptômes <48h, 
une consultation en début d'épidémie, une température > 37.8° et une toux (sensibilité 79%, 
spécificité 69%, valeur prédictive positive 67%, une valeur prédictive négative de 73% et aire 
sous la courbe (ROC) de 0.74). 
En plus des signes et symptômes prédicteurs de la grippe, le médecin de premier recours 
devrait prendre en compte dans son jugement la durée des symptômes avant la première 
consultation et le contexte épidémiologique (début, pic, fin de l'épidémie), car ces deux 
paramètres modifient considérablement la valeurs des prédicteurs lors de l'évaluation de la 
probabilité clinique d'un patient d'avoir une infection à Influenza. 
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Abstract 
Questions under study: The diagnostic performance of clinical symptoms/signs of influenza 
has mainly been assessed in the context of controlled studies with stringent inclusion criteria. 
There was a need to extend the evaluation of these predictors in the context of general 
practice, and according to the duration of symptoms and to the dynamics of the epidemic. 
Principles: Prospective study conducted in the Medical Outpatient Clinic, winter season 
1999-2000. Patients with influenza-like syndrome were included, as long as the primary care 
physician envisaged the diagnosis of influenza. A questionnaire was administered by the 
physician, a throat swab was performed and a culture to document the diagnostic of influenza. 
Results: 201 patients were included in the study. 52% were culture positive for influenza. By 
univariate analysis, a temperature >37.8°C (OR 4.2; 95% CI 2.3-7.7), a duration of symptoms 
<48 hours (OR 3.2; 1.8-5.7), cough (OR 3.2; 1-10.4) and myalgia (OR 2.8; 1.0-7.5) were 
associated with a diagnosis of influenza. In a multivariable logistic analysis, the best model 
predicting influenza was the association of a duration of symptom < 48 hours, medical 
attendance at the beginning of the epidemic (weeks 49-50), fever > 37.8 and cough, with a 
sensitivity of 79%, specificity of 69%, positive predictive value of 67%, negative predictive 
value of73% and an area under the ROC curve of0.74 
Conclusions: Besicles relevant symptoms and signs, the physician should also consider the 
duration of symptoms and the epidemiological context (start, peak or end of the epidemic) in 
his judgement, since both parameters modify considerably the value of the clinical predictors 
when assessing the probability of a patient to have influenza. 
Key-words : influenza, clinicat predictors, clinicat diagnosis, epidemic, time 
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Introduction 
The recent marketing of antiviral drugs against influenza has changed the diagnostic approach 
of this disease. Indeed, there is a need to quickly make the diagnosis so that the new drugs can 
be used appropriately [1-3]. The general practitioner needs epidemiological, clinical and/or 
laboratory tools to improve the reliability of the diagnosis of influenza at first attendance. 
The diagnostic performance of clinical symptoms/signs of influenza has mainly been assessed 
in the context of controlled studies ( clinical trials of new antiviral drugs) o:ften using stringent 
inclusion criteria. A temperature >37.8°C, cough and sudden onset of symptoms have been 
identi:fied as indicators of influenza [4-11]. In the present study, we wanted to assess these 
predictors in the context of general practice and more importantly, the magnitude of their 
variation according to the duration of symptoms and the dynamic of the epidemic (start, peak 
and end). 
Methods 
Design: 
Prospective study conducted during the winter season 1999-2000 at the Medical Outpatient 
Clinic, University of Lausanne, Switzerland, a primary care centre that serves an urban 
population of approximately 150,000 inhabitants. The study was conducted within a national 
surveillance programme of influenza epidemics in Switzerland called Sentinella [12]. All 
along the year, naso-pharyngal swabs are collected and tested for influenza and other 
infectious diseases from several institutions (outpatient clinics) and private practices in 
Switzerland, in ordrer to detect and monitor epidemics outbreaks. The proportion of medical 
consultations for influenza-like illness (% MC-ILI) is also reported, and is used to describe 
the dynamic of epidemic of influenza (the threshold to define an epidemic is 1.5% ). 
Patients and procedure: 
Patients were recruited in the study by the physician on duty, if he/she felt that the symptoms 
or signs were compatible with a diagnosis of influenza. There were no specific criteria for 
inclusion or exclusion (such as those of Sentinella surveillance in Switzerland, for example) 
in order to avoid selection bias (patient with a high pre-test probability) and to reflect the real 
practice. A:fter oral consent, the physician administered a questionnaire to the patient to 
collect demographic (i.e. age, sex) and clinical data (i.e. symptoms of cough, sore throat, 
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rhinitis, myalgia, headache, fatigue, chills/sweating, as well as the duration of symptoms :from 
onset to medical attendance and signs, mainly axillary temperature ).A threshold value of 
37.8° was used to define fever as in most of the other studies [3].A throat-swab was 
performed and sent in medium (Leibowitz, BSA, bicarbonate, hybrimax and gentamycin) to 
the reference laboratory for the Sentinella Surveillance Program (IKMI, St-Galien, 
Switzerland) for a MDCK culture in order to identify influenza A and B viruses. 
Data analysis: 
To measure the association between the explanatory variables ( duration of the symptoms, the 
period of the consultation, axillary temperature of >37.8°C, cough, sore throat, rhinitis, 
myalgia, headache, fatigue, chills/sweating), and the outcome variable (presence of influenza 
A or B in throat swab culture), we estimated the odds ratio with the pro gram CIA 
SOFTWARE version 2.0.0 from BMJ using univariate analysis. For each of these variables, 
we estimated the sensitivity (Se), specificity (Sp ), positive and negative predictive values 
(PPV/NPV). 
We then built an multivariable logistic model using STATA 8.2 software, starting with a 
simple model including only duration of symptoms and period of consultation. The categories 
for the duration of symptoms were < 24 h, 24-48h and > 48h. The categories for the time-
period of consultation were: week 49-51 (pre-epidemic ), 52-1 (peak of the epidemic) and > 1 
(post-epidemic) [based on the proportion of medical consultations due to flu-like syndromes 
estimated by the Swiss infectious disease surveillance system (Sentinella)]. We added step by 
step those clinical variables with odds ratio higher than one. We retained in the model 
variables for which the estimated odds ratio was > 1 ( p-value <0.05). Going backwards, we 
proceeded to a simplification in the definition of the categorical variables, using the deviance 
statistic to judge the loss of diagnostic power. The ROC curves of both the initial and the final 
models were computed, as well as the sensitivity, specificity, PPV and NPV. 
Results 
This study was conducted from December 1999 to February 2000. 222 patients were included 
in the study and 21 patients with incomplete data or where no throat-swab had been done 
were excluded :from the analysis, soit remained 201 patients. 104of201 (52%) had a positive 
throat-swab for influenza, of which 103 for influenza A and 1 for influenza B. The mean age 
was similar in the group with positive culture (mean = 34.3 years, SD = 13) than the one with 
negative culture (mean = 34.3, SD = 12). Height patients were aged more than 60 years and 
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half of them were positive for influenza. The demographical characteristics as well as the 
prevalence of symptoms and signs among cases of influenza vs controls are summarised in 
table 1. 
By univariate analysis, temperature >37.8°, cough, duration of symptoms <48 hours before 
consultation and myalgia were associated with a diagnosis of influenza. 
Table 2 shows the diagnostic performance (PPV, NPV, sensitivity and specificity) of clinical 
variables for the diagnosis of influenza. 
We started to construct the multivariable logistic model with the two variables: time-period of 
consultation and duration of symptoms before first medical attendance, each divided in 3 
categories as described in the data analysis section. In this situation the area under the ROC 
curve was 0.69 with a prediction rule of 0.5, Se was 64% (IC 95% 54-74), Sp 64% (54-73), 
PPV 66%(56-75) and NPV 63% (52-72) (see figure 1). We then added step by step the 
variables with a estimated OR > 1, temperature > 37.8, cough, and myalgia. The latter 
symptom added nothing to the power of the model and was thus withdrawn. After that, we 
replaced temperature > 37.8° by continuous temperature measurement. We then simplified the 
3 time-period categories into two(week 49-50 and week 51-5) and also the 3 categories of 
duration of symptoms into two ( < 48h and >48h) without changing the power of our model. 
Finally, the model with 2 categories for time-period of consultation and duration of 
symptoms, continuous temperature and cough had an area under the ROC curve of 0.76 with 
a Se of74% (65-82), Sp of 69% (59-78), PPV of72% (62-80) and NPV of71% (61-80) (see 
figure 2). When we replaced continuous temperature by categorical temperature > 37.8, the 
area under the ROC curve was 0.74 with a Se of 80% (70-87), Sp of 59% (48-69), PPV of 
67% (58-76) and NPV of73% (62-82) (see figure 3). 
Discussion 
The present study shows that the best model for the prediction of influenza in clinical practice 
is the association of a duration between symptom onset and first medical consultation <48 
hours, medical attendance at the beginning of the epidemic, a temperature >37.8°C, and 
cough. The model was, even better when we used temperature as a continuo us measurement, 
meaning that the highest the temperature was, the better the prediction. However in practice it 
is much easier to use a fixed threshold (> 37.8°). 
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Temperature > 37.8° and cough were good clinical predictors of influenza, which is in line 
with the results described in previous studies conducted in selected populations aimed at 
assessing the safety and efficacy of antiviral drugs [ 4-11, 13]. This means that primary care 
physicians can also safely use these predictors to guide their practice. 
According to our results, the time must also be considered in presence of clinical signs and 
symptoms suggesting influenza. Indeed, a duration of symptoms less than 48 hours, and first 
medical attendance at the beginning of the epidemic were also good predictors for the positive 
diagnostic of influenza in the presence of fever and cough . The primary care physician 
should therefore consider the duration of symptoms and the time of the epidemic when 
assessing the probability of his/her patient to have a diagnosis of influenza in the presence of 
a known clinical predictor. 
In summary, the probability of having influenza is highest when the patient attends rapidly 
after symptom onset, at the beginning of the epidemic and in the presence of a temperature 
>37.8°C + cough. At the peak of the epidemic, almost all patients have influenza, irrespective 
of their symptoms and signs. The clinical predictors, as well as the rapid diagnostic tests (due 
to the important variability of speci:ficity of these assays [ 14-16]) loose thus their usefulness at 
that time. The time period of consultation dming and around the epidemic influencing the 
prediction of influenza highlights the necessity for the clinician to consider the 
epidemiological context at the time of consultation, when estimating the probability of his/her 
patient to have influenza. 
The identification of clinical predictors of influenza, as well as a fair estimation of their 
variability in time, should help to establish clinical scores that could be used by the general 
practitioner to optimise the care of patients in terms of rapid diagnostic tests use and antiviral 
therapy initiation. 
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Table 1: demographical % (number) of % (number) 
characteristics and patients with patients with prevalence of symptoms Characteristics Odds Ratio* CI95 % 
and signs among cases of positive culture negative culture 
influenza (culture+) vs (n=104) (n=97) 
controls (culture-) 
Female sex 53 (55) 46 (44) 1.3 0,8 -2.3 
Duration of symptoms before 
66 (69) 38 (37) 3.2 1.8 - 5.7 medical attendance < 48h 
Time-period of consultation 
weeks 49-50 (pre-epidemic) 26 (27) 28 (27) 2.3 1.2-4.5 
weeks 51-5 ( epidemic and post-
epidemic) 74 {77) 72 {702 ref 1.1-9.9 
Temperature >37.8°C 74 {77) 40 (39) 4.2 2.3 -7.7 
Cough 96 (100) 89 (86) 3.2 1.0 10.4 
Temperature > 37,8 and cough 72 (75) 37 (36) 4.4 2.4 -7.9 
Sore throat 75 (782 75 (73) 0.5 - 1.9 
Myalgia 94 (98) 86 (83) 2.8 1.0 - 7.5 
Rhinitis 81 (84) 81 (79) l 0.5 -1.9 
Headache 85 (88) 84 (812 1.1 0.5 -2.3 
Fatigue 91 (95) 92 (892 0.4 -2.6 
Chills/sweating 88 (91) 77 (75) 2.1 1.0 4.4 
* by univariate analysis 
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Table 2 : diagnostic 
symptoms and performance: Positive PPV NPV Se Sp Predictive Value (PPV), signs 
sensitivity (Se) and 
specificity (Sp) ) of Cough 54 73 96 11 
clinical variables for the Sore throat 52 48 75 25 diagnosis of influenza 
Rhinitis 52 47 81 19 
Myalgia 54 70 94 14 
Headache 52 50 85 17 
Fatigue 52 47 91 8 
Duration of 65 63 66 62 
syrnptoms < 48h 
Chills/sweating 55 63 88 23 
Temperature 66 68 74 60 
>37,8 
Cough + Temp. 68 68 72 63 
> 37,8 
Figure 1 ROC curve, model with the two variables: time-period of consultation (weeks 
49-51, 52-1 and > 1) and duration of symptoms before first medical attendance ( < 24 h, 
24-48h, >48h). 
>-
:t: 
:§g 
(/) . 
CO 
(]) 
en 
0 
~ 
0 
0.00 0.25 
Area under ROC curve = 0.6975 
0.50 0.75 1.00 
1 - Spedficity 
11 
Figure 2 ROC curve, model with the four variables: time-period of 
consultation (weeks 49-50, 51-5), duration of symptoms before first medical 
attendance ( < 48h, >48h), continuo us temperature and cough. 
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Figure 3 ROC curve, model with the four variables: time-period of consultation (weeks 49-50, 
51-5), duration of symptoms before first medical attendance ( < 48h, >48h), temperature > 
37.8° and cough. 
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